These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7748309)

  • 1. The effects of 5-HT3 receptor antagonists in models of dependency and withdrawal.
    Costall B; Domeney AM; Kelly ME; Naylor RJ
    Alcohol Alcohol Suppl; 1993; 2():269-73. PubMed ID: 7748309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritanserin and alcohol abuse and dependence.
    Meert TF
    Alcohol Alcohol Suppl; 1994; 2():523-30. PubMed ID: 8974378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the effects of certain 5-HT-3 receptor antagonists on ethanol preference and withdrawal seizures in the rat.
    Kostowski W; Bisaga A; Jankowska E; Krzaścik P
    Pol J Pharmacol; 1994; 46(3):133-7. PubMed ID: 8000444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
    Sellers EM; Higgins GA; Tomkins DM; Romach MK; Toneatto T
    J Clin Psychiatry; 1991 Dec; 52 Suppl():49-54. PubMed ID: 1752860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake.
    Mhatre M; Pruthi R; Hensley K; Holloway F
    Eur J Pharmacol; 2004 May; 491(2-3):149-56. PubMed ID: 15140631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT receptors: implications for the neuropharmacology of alcohol and alcoholism.
    Overstreet DH; Rezvani AH; Pucilowski O; Janowsky DS
    Alcohol Alcohol Suppl; 1994; 2():205-10. PubMed ID: 8974337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT3 receptors and central effects of ethanol.
    Kostowski W
    Pol J Pharmacol; 1996; 48(3):243-54. PubMed ID: 9112659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New benzamide-derived 5-HT3 receptor antagonists which prevent the effects of ethanol on extracellular dopamine, and fail to reduce voluntary alcohol intake in rats.
    Iusco G; Boido V; Sparatore F; Colombo G; Saba PL; Rossetti Z; Vaccari A
    Farmaco; 1997 Mar; 52(3):141-6. PubMed ID: 9212448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT(3A) receptor subunit is required for 5-HT3 antagonist-induced reductions in alcohol drinking.
    Hodge CW; Kelley SP; Bratt AM; Iller K; Schroeder JP; Besheer J
    Neuropsychopharmacology; 2004 Oct; 29(10):1807-13. PubMed ID: 15162158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake.
    Le AD; Sellers EM
    Alcohol Alcohol Suppl; 1994; 2():545-9. PubMed ID: 8974381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plea for abrupt alcohol withdrawal in the therapy of the acute alcohol withdrawal syndrome.
    Miller BH
    Va Med Mon (1918); 1968 Jul; 95(7):404-11. PubMed ID: 5665133
    [No Abstract]   [Full Text] [Related]  

  • 12. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
    Tsukagoshi S; Ohta J; Taguchi T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for the drug therapy of alcoholism].
    Gessa GL
    Recenti Prog Med; 1990 Mar; 81(3):171-5. PubMed ID: 2359869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.
    Ait-Daoud N; Malcolm RJ; Johnson BA
    Addict Behav; 2006 Sep; 31(9):1628-49. PubMed ID: 16472931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic anti-depressants and ethanol withdrawal syndrome: a review.
    Uzbay IT
    Alcohol Alcohol; 2008; 43(1):15-24. PubMed ID: 17934195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
    Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatments for alcohol dependence and withdrawal--an historical perspective.
    Taberner PV
    Alcohol Alcohol Suppl; 1993; 2():259-62. PubMed ID: 7748307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats.
    Martijena ID; Bustos SG; Bertotto ME; Molina VA
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine on ethanol withdrawal syndrome in rats.
    Kayir H; Uzbay T
    Alcohol Alcohol; 2008; 43(6):619-25. PubMed ID: 18579515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.